ArticleFrontiers in oncology2022

Integration of Inflammation-Immune Factors to Build Prognostic Model Predictive of Prognosis and Minimal Residual Disease for Hepatocellular Carcinoma.

Xin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.